Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131409) titled 'A Randomized, Double-Blind, Placebo-Controlled Clinical Study of Inactivated Akkermansia for Improving Body Fat and Metabolism in Overweight Adults' on Sept. 2.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Nanchang Reproductive Hospital

Condition: Overweight

Intervention: placebo group:placebo

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-02

Target Sample Size: placebo group:50;iAKK group:50;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=341265

Disclaimer: Curated by HT Syndication....